Literature DB >> 14551053

Do P2X purinergic receptors regulate skeletal muscle blood flow during exercise?

John B Buckwalter1, Jessica C Taylor, Jason J Hamann, Philip S Clifford.   

Abstract

Although there is evidence that sympathetic nerves release ATP as a neurotransmitter to produce vasoconstriction via P2X purinergic receptors, the role of these receptors in the regulation of blood flow to exercising skeletal muscle has yet to be determined. We hypothesized that there is tonic P2X receptor-mediated vasoconstriction in exercising skeletal muscle. To test this hypothesis, the effect of P2X receptor blockade on skeletal muscle blood flow was examined in six exercising mongrel dogs. P2X receptor antagonism was accomplished with pyridoxal-phosphate-6-azophenyl-2'4'-disulfonic acid (PPADs). Animals were instrumented chronically with flow probes on the external iliac arteries of both hindlimbs and a catheter in one femoral artery. PPADs (40 mg) was infused as a bolus into the femoral artery catheter during steady-state exercise at 6 miles/h. Intra-arterial infusion of PPADs increased iliac blood flow from 542 +/- 55 to 677 +/- 69 ml/min (P < 0.05) and iliac vascular conductance from 5.17 +/- 0.62 to 6.53 +/- 0.80 ml.min(-1).mmHg(-1). The PPADs infusion did not affect blood flow in the contralateral iliac artery. These data support the hypothesis that P2X purinergic receptors produce vasoconstriction in exercising skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551053     DOI: 10.1152/ajpheart.00572.2003

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  11 in total

1.  From one generation to the next: a comprehensive account of sympathetic receptor control in branching arteriolar trees.

Authors:  Baraa K Al-Khazraji; Amani Saleem; Daniel Goldman; Dwayne N Jackson
Journal:  J Physiol       Date:  2015-07-15       Impact factor: 5.182

Review 2.  Regulation of increased blood flow (hyperemia) to muscles during exercise: a hierarchy of competing physiological needs.

Authors:  Michael J Joyner; Darren P Casey
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

3.  Tripartite function of ATP in vascular signalling.

Authors:  Philip S Clifford
Journal:  J Physiol       Date:  2008-10-15       Impact factor: 5.182

4.  The effect of aging on adrenergic and nonadrenergic receptor expression and responsiveness in canine skeletal muscle.

Authors:  D S Delorey; P S Clifford; S Mittelstadt; M M Anton; H A Kluess; J D Tune; U D Dincer; J B Buckwalter
Journal:  J Appl Physiol (1985)       Date:  2011-12-22

5.  Is tonic sympathetic vasoconstriction increased in the skeletal muscle vasculature of aged canines?

Authors:  D S DeLorey; J B Buckwalter; S W Mittelstadt; M M Anton; H A Kluess; P S Clifford
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-08-11       Impact factor: 3.619

6.  Sources of intravascular ATP during exercise in humans: critical role for skeletal muscle perfusion.

Authors:  Brett S Kirby; Anne R Crecelius; Jennifer C Richards; Frank A Dinenno
Journal:  Exp Physiol       Date:  2013-01-11       Impact factor: 2.969

7.  Effect of extraluminal ATP application on vascular tone and blood flow in skeletal muscle: implications for exercise hyperemia.

Authors:  Michael Nyberg; Baraa K Al-Khazraji; Stefan P Mortensen; Dwayne N Jackson; Christopher G Ellis; Ylva Hellsten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-06-12       Impact factor: 3.619

8.  ATP overflow in skeletal muscle 1A arterioles.

Authors:  Heidi A Kluess; Audrey J Stone; Kirk W Evanson
Journal:  J Physiol       Date:  2010-06-21       Impact factor: 5.182

9.  Exercise training and α1-adrenoreceptor-mediated sympathetic vasoconstriction in resting and contracting skeletal muscle.

Authors:  Timothy P Just; Darren S DeLorey
Journal:  Physiol Rep       Date:  2016-02

10.  ATP metabolism in skeletal muscle arterioles.

Authors:  Audrey J Stone; Kirk W Evanson; Heidi A Kluess
Journal:  Physiol Rep       Date:  2014-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.